JPH10504029A - てんかん性疾患の治療のためのセレギリンの使用 - Google Patents
てんかん性疾患の治療のためのセレギリンの使用Info
- Publication number
- JPH10504029A JPH10504029A JP8506905A JP50690596A JPH10504029A JP H10504029 A JPH10504029 A JP H10504029A JP 8506905 A JP8506905 A JP 8506905A JP 50690596 A JP50690596 A JP 50690596A JP H10504029 A JPH10504029 A JP H10504029A
- Authority
- JP
- Japan
- Prior art keywords
- selegiline
- treatment
- epileptic
- case
- pct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.てんかん性疾患の治療医薬品の製造ための、セレギリンもしくは該化合物 の製剤学的に使用可能な塩の使用。 2.殊に痙攣の抑制及び上記疾患の進行の遅延のための、請求項1記載のセレ ギリンもしくは該化合物の製剤学的に使用可能な塩の使用。 3.請求項1記載の化合物を含有している、抗てんかん作用を有する医薬品。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4428444A DE4428444A1 (de) | 1994-08-11 | 1994-08-11 | Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen |
DE4428444.6 | 1994-08-11 | ||
PCT/DE1995/000981 WO1996004897A1 (de) | 1994-08-11 | 1995-07-27 | Verwendung von selegilin zur behandlung von epileptischen erkrankungen |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH10504029A true JPH10504029A (ja) | 1998-04-14 |
JP3922307B2 JP3922307B2 (ja) | 2007-05-30 |
Family
ID=6525440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50690596A Expired - Fee Related JP3922307B2 (ja) | 1994-08-11 | 1995-07-27 | てんかん性疾患の治療のためのセレギリンの使用 |
Country Status (23)
Country | Link |
---|---|
US (1) | US5952388A (ja) |
EP (1) | EP0774961B1 (ja) |
JP (1) | JP3922307B2 (ja) |
CN (1) | CN1081918C (ja) |
AT (1) | ATE239458T1 (ja) |
AU (1) | AU691316B2 (ja) |
BR (1) | BR9508531A (ja) |
CA (1) | CA2197176C (ja) |
CZ (1) | CZ285681B6 (ja) |
DE (2) | DE4428444A1 (ja) |
DK (1) | DK0774961T3 (ja) |
EE (1) | EE04176B1 (ja) |
ES (1) | ES2199252T3 (ja) |
HU (1) | HU223529B1 (ja) |
MY (1) | MY116362A (ja) |
NO (1) | NO314684B1 (ja) |
PL (1) | PL188040B1 (ja) |
PT (1) | PT774961E (ja) |
RU (1) | RU2155584C2 (ja) |
SK (1) | SK283205B6 (ja) |
TR (1) | TR199500984A2 (ja) |
TW (1) | TW448044B (ja) |
WO (1) | WO1996004897A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19630035A1 (de) * | 1996-07-25 | 1998-01-29 | Asta Medica Ag | Tramadol Multiple Unit Formulierungen |
DE19716905C1 (de) * | 1997-04-22 | 1998-08-27 | Iip Inst Fuer Ind Pharmazie Fo | Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung |
DE19743323C2 (de) * | 1997-09-30 | 2000-05-25 | Iip Inst Fuer Ind Pharmazie Fo | Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin |
NZ532583A (en) * | 2001-11-05 | 2006-12-22 | Krele Pharmaceuticals | Compositions and methods for increasing compliance using aldehyde dehydrogenase inhibitors ( ALDH ) such as disulfiram and monoamine oxidase B inhibitors ( MAOB ) such as selegiline |
GB201715919D0 (en) * | 2017-09-29 | 2017-11-15 | Gw Res Ltd | use of cannabinoids in the treatment of epilepsy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5192808A (en) * | 1990-08-31 | 1993-03-09 | Deprenyl Animal Health, Inc. | Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease) |
AU1450592A (en) * | 1991-04-04 | 1992-11-02 | University Of Toronto Innovations Foundation, The | Use of deprenyl to maintain, prevent loss, or recover nerve cell function |
US5648087A (en) * | 1993-03-09 | 1997-07-15 | Sanofi Sante Nutrition Animale | Anaesthetic pharmaceutical composition comprising a general anaesthetic and selegiline |
US5462740A (en) * | 1993-09-17 | 1995-10-31 | Athena Neurosciences, Inc. | Rectally-administered, epileptic-seizure-inhibiting composition |
-
1994
- 1994-08-11 DE DE4428444A patent/DE4428444A1/de not_active Withdrawn
-
1995
- 1995-07-17 TW TW084107378A patent/TW448044B/zh not_active IP Right Cessation
- 1995-07-27 JP JP50690596A patent/JP3922307B2/ja not_active Expired - Fee Related
- 1995-07-27 CZ CZ97407A patent/CZ285681B6/cs not_active IP Right Cessation
- 1995-07-27 EE EE9700068A patent/EE04176B1/xx not_active IP Right Cessation
- 1995-07-27 CA CA002197176A patent/CA2197176C/en not_active Expired - Fee Related
- 1995-07-27 WO PCT/DE1995/000981 patent/WO1996004897A1/de active IP Right Grant
- 1995-07-27 BR BR9508531A patent/BR9508531A/pt not_active Application Discontinuation
- 1995-07-27 ES ES95925732T patent/ES2199252T3/es not_active Expired - Lifetime
- 1995-07-27 RU RU97104062/14A patent/RU2155584C2/ru not_active IP Right Cessation
- 1995-07-27 US US08/776,931 patent/US5952388A/en not_active Expired - Fee Related
- 1995-07-27 EP EP95925732A patent/EP0774961B1/de not_active Expired - Lifetime
- 1995-07-27 PT PT95925732T patent/PT774961E/pt unknown
- 1995-07-27 AT AT95925732T patent/ATE239458T1/de not_active IP Right Cessation
- 1995-07-27 HU HU9700405A patent/HU223529B1/hu not_active IP Right Cessation
- 1995-07-27 CN CN95194569A patent/CN1081918C/zh not_active Expired - Fee Related
- 1995-07-27 AU AU29760/95A patent/AU691316B2/en not_active Ceased
- 1995-07-27 PL PL31829295A patent/PL188040B1/pl not_active IP Right Cessation
- 1995-07-27 DK DK95925732T patent/DK0774961T3/da active
- 1995-07-27 SK SK199-97A patent/SK283205B6/sk not_active IP Right Cessation
- 1995-07-27 DE DE59510674T patent/DE59510674D1/de not_active Expired - Fee Related
- 1995-07-31 MY MYPI95002228A patent/MY116362A/en unknown
- 1995-08-09 TR TR95/00984A patent/TR199500984A2/xx unknown
-
1997
- 1997-02-10 NO NO19970607A patent/NO314684B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lindvall et al. | Transplantation of fetal dopamine neurons in Parkinson's disease: one‐year clinical and neurophysiological observations in two patients with putaminal implants | |
JP5542291B2 (ja) | 注意不足機能亢進障害および多発性硬化症疲労の治療のためのモダフィニルを含む組成物 | |
EP1908461B9 (fr) | Utilisation de l'énantiomère (1S, 2R) du milnacipran pour la préparation d'un médicament | |
JP2000508318A (ja) | 神経細胞の保護方法 | |
EP2305225A1 (fr) | Utilisation de l'enantiomere (1s, 2r) du milnacipran pour la preparation d'un medicament | |
JP2012197304A (ja) | ミオパシー関連性の覚醒障害を矯正することが意図される医薬品を製造するためのモダフィニルの使用 | |
JP2009501223A (ja) | 癲癇発生の処置法 | |
JPH10504029A (ja) | てんかん性疾患の治療のためのセレギリンの使用 | |
MXPA00012808A (es) | El uso de analogo de acido valproico para tratamiento y prevencion de migrana y enfermedad afectiva. | |
Knoll | Antiaging Compounds:(‐) Deprenyl (Selegiline) and (‐) 1‐(Benzofuran‐2‐yl)‐2‐propylaminopentane,[(‐) BPAP], a Selective Highly Potent Enhancer of the Impulse Propagation Mediated Release of Catecholamines and Serotonin in the Brain | |
Heikkila et al. | Potentiation by deprenil of l-dopa induced circling in nigral-lesioned rats | |
Rinne et al. | Brain dopamine receptor stimulation and the relief of parkinsonism: relationship between bromocriptine and levodopa | |
WO2005120200A2 (en) | Amine compounds and inhibiting neurotransmitter reuptake | |
Austin et al. | Studies of connections between locus coeruleus and cerebral cortex | |
EP2104533B1 (de) | Verwendung von substanzen, die den zellulären glutathion-gehalt absenken, zur herstellung eines arzneimittels zur behandlung von t-zell-vermittelten autoimmunkrankheiten | |
Rinne et al. | Brain dopamine turnover and the relief of parkinsonism | |
US20070225236A1 (en) | Methods for the prevention and/or the treatment of glutamate cytotoxicity | |
EP1776097A1 (en) | Methods of treating ophthalmic conditions | |
Gaillard | Brain catecholaminergic activity in relation to sleep | |
MXPA97001031A (en) | Utilization of selegiline for the treatment of epilepti diseases | |
TWI291872B (en) | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue | |
MXPA06001392A (es) | Metodos para el tratamiento de sindrome metabolico. | |
Roufs | L-tyrosine in the treatment of narcolepsy | |
JP2012102069A (ja) | 早漏治療剤 | |
Manasa | Experimental evaluation of anticonvulsant activity of Hydrocotyle asiatica linn (Centella asiatica) in Albino mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051101 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060125 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060313 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060428 |
|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20061115 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070123 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070213 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |